Index of reports
> Cases with Hypertensive Crisis (1)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Labetalol where reactions include hypertensive crisis. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Labetalol side effects in female
Reported by a consumer/non-health professional from United States on 2012-03-22
Patient: female, weighing 65.4 kg (143.9 pounds)
Reactions: Blood Pressure Increased, Dyspnoea, Labile Hypertension, Drug Ineffective, Urinary Incontinence, Blood Potassium Increased, Headache, Hypertensive Crisis, Overdose, Bronchitis, Cough, Atrioventricular Block First Degree
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Labetalol
Dosage: 1 df, qid
Levothroid
Dosage: 600 ug, unk
Administration route: Oral
Levothroid
Dosage: 300 ug, unk
Administration route: Oral
Gilenya
Dosage: 0.5 mg, qd
Administration route: Oral
Indication: Multiple Sclerosis
Start date: 2011-06-06
End date: 2011-11-04
Labetalol
Dosage: 1 df, q6h
Administration route: Oral
Catapres
Dosage: 0.1 mg, tid (prn)
Administration route: Oral
Zestril
Dosage: 10 mg, bid
Labetalol
Dosage: 900 mg, once/single
Administration route: Oral
Lopressor
Dosage: 50 mg, tid
Administration route: Oral
Catapres
Dosage: 0.1 mg, tid (prn)
Administration route: Oral
Cardizem LA
Dosage: unk ukn, unk
Indication: Coronary Artery Disease
Other drugs received by patient: Synthroid; Aldactone; Amitiza; Clonidine; Aldactone; Prozac; Prilosec; Vitamin D; Valium; Dyazide; Valium
|